HomeCompareDSKYF vs VICI

DSKYF vs VICI: Dividend Comparison 2026

DSKYF yields 2.50% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DSKYF wins by $174.62M in total portfolio value· pulled ahead in Year 4
10 years
DSKYF
DSKYF
● Live price
2.50%
Share price
$18.42
Annual div
$0.46
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$175.59M
Annual income
$163,081,726.45
Full DSKYF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — DSKYF vs VICI

📍 DSKYF pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDSKYFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DSKYF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DSKYF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DSKYF
Annual income on $10K today (after 15% tax)
$212.91/yr
After 10yr DRIP, annual income (after tax)
$138,619,467.48/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, DSKYF beats the other by $138,103,197.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DSKYF + VICI for your $10,000?

DSKYF: 50%VICI: 50%
100% VICI50/50100% DSKYF
Portfolio after 10yr
$88.28M
Annual income
$81,844,551.28/yr
Blended yield
92.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

DSKYF
No analyst data
Altman Z
3.4
Piotroski
6/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DSKYF buys
0
VICI buys
0
No recent congressional trades found for DSKYF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDSKYFVICI
Forward yield2.50%6.52%
Annual dividend / share$0.46$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%44.3%
Portfolio after 10y$175.59M$966.2K
Annual income after 10y$163,081,726.45$607,376.13
Total dividends collected$174.63M$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DSKYF vs VICI ($10,000, DRIP)

YearDSKYF PortfolioDSKYF Income/yrVICI PortfolioVICI Income/yrGap
1$11,201$500.97$11,361$941.49$160.00VICI
2$13,034$1,048.84$13,320$1,481.32$286.00VICI
3$16,228$2,281.26$16,284$2,405.01$56.00VICI
4← crossover$22,672$5,308.83$21,040$4,071.78+$1.6KDSKYF
5$38,123$13,863.99$29,209$7,285.49+$8.9KDSKYF
6$84,366$43,574.29$44,443$14,006.51+$39.9KDSKYF
7$270,513$180,241.39$75,822$29,512.55+$194.7KDSKYF
8$1,369,690$1,080,240.94$148,733$69,726.75+$1.22MDSKYF
9$11,689,092$10,223,523.95$344,394$189,413.75+$11.34MDSKYF
10$175,589,055$163,081,726.45$966,234$607,376.13+$174.62MDSKYF

DSKYF vs VICI: Complete Analysis 2026

DSKYFStock

Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihypertensive agent; levofloxacin, an antibacterial agent; pravastatin for hypercholesterolemia treatment; and loxoprofen, an anti-inflammatory analgesic. In addition, the company offers colesevelam for treating hypercholesterolemia and type 2 diabetes mellitus treatment; and ferric carboxymaltose and iron sucrose injections for treating anemia. Further, it provides Lulu, a combination cold remedy; Loxonin S, an antipyretic analgesic /anti-inflammatory analgesic; Transino for melasma improvement and treating against spots and freckles; Minon, a skincare product; and Breath Labo and Clean Dental oral care products, as well as Silodosin for dysuria; Gefitinib for malignant tumours; Bicalutamide for prostate cancer; and Tamoxifen, an anti-breast cancer agent. Additionally, the company offers adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. It also provides pharmaceuticals and drugs for animals, cosmetics, medical equipment, food products, drinking water, active pharmaceutical ingredients, and intermediates. It has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer. The company was founded in 1899 and is headquartered in Tokyo, Japan.

Full DSKYF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this DSKYF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DSKYF vs SCHDDSKYF vs JEPIDSKYF vs ODSKYF vs KODSKYF vs MAINDSKYF vs NNNDSKYF vs EPRTDSKYF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.